NDC 61703-305

Cytarabine

Cytarabine

Cytarabine is a Intrathecal; Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Cytarabine.

Product ID61703-305_2f1e0d27-db5b-4e1c-bc4e-956da5dd7117
NDC61703-305
Product TypeHuman Prescription Drug
Proprietary NameCytarabine
Generic NameCytarabine
Dosage FormInjection, Solution
Route of AdministrationINTRATHECAL; INTRAVENOUS; SUBCUTANEOUS
Marketing Start Date1990-06-04
Marketing CategoryANDA / ANDA
Application NumberANDA071868
Labeler NameHospira, Inc.
Substance NameCYTARABINE
Active Ingredient Strength20 mg/mL
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 61703-305-38

5 VIAL, SINGLE-DOSE in 1 CARTON (61703-305-38) > 5 mL in 1 VIAL, SINGLE-DOSE (61703-305-58)
Marketing Start Date1990-06-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61703-305-58 [61703030558]

Cytarabine INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA071868
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-06-19

NDC 61703-305-38 [61703030538]

Cytarabine INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA071868
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1990-06-04

Drug Details

Active Ingredients

IngredientStrength
CYTARABINE20 mg/mL

OpenFDA Data

SPL SET ID:bc2fa221-ea56-48b8-8304-42cd81b8463b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1731355

    • Pharmacological Class

    • Nucleic Acid Synthesis Inhibitors [MoA]
    • Nucleoside Metabolic Inhibitor [EPC]

    NDC Crossover Matching brand name "Cytarabine" or generic name "Cytarabine"

    NDCBrand NameGeneric Name
    61703-303CYTARABINECYTARABINE
    61703-304CytarabineCYTARABINE
    61703-305CytarabineCYTARABINE
    61703-319CytarabineCYTARABINE
    63323-120CytarabineCYTARABINE
    67457-452CytarabineCytarabine
    67457-454CytarabineCytarabine
    67457-455cytarabinecytarabine
    68083-337CytarabineCytarabine
    68083-343CytarabineCytarabine
    71288-108CytarabineCytarabine
    71288-109CytarabineCytarabine
    71288-168CytarabineCytarabine
    71288-169CytarabineCytarabine
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.